Ryan Specialty (RYAN) Projected to Announce Quarterly Earnings on Thursday

Ryan Specialty (NYSE:RYAN) is anticipated to post its Q2 2026 results after the market closes on Thursday, July 30th. Analysts expect Ryan Specialty to announce earnings of $0.61 per share and revenue of $873.93 million for the quarter. Parties may visit the the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, July 30, 2026 at 4:45 PM ET.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.04. Ryan Specialty had a return on equity of 41.33% and a net margin of 8.21%.The firm had revenue of $795.23 million during the quarter, compared to the consensus estimate of $781.44 million. During the same period last year, the company earned $0.39 earnings per share. The company’s revenue for the quarter was up 15.2% on a year-over-year basis. On average, analysts expect Ryan Specialty to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Ryan Specialty Stock Performance

NYSE:RYAN opened at $39.32 on Thursday. The company has a debt-to-equity ratio of 2.90, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market cap of $10.37 billion, a price-to-earnings ratio of 51.06, a price-to-earnings-growth ratio of 0.89 and a beta of 0.61. The firm’s fifty day moving average price is $36.22 and its 200 day moving average price is $38.72. Ryan Specialty has a 1-year low of $29.28 and a 1-year high of $66.27.

Ryan Specialty Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, May 26th. Stockholders of record on Tuesday, May 12th were paid a $0.13 dividend. This represents a $0.52 annualized dividend and a dividend yield of 1.3%. The ex-dividend date was Tuesday, May 12th. Ryan Specialty’s dividend payout ratio (DPR) is 67.53%.

Ryan Specialty announced that its Board of Directors has authorized a stock buyback plan on Tuesday, May 26th that permits the company to repurchase $300.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 3.5% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.

Insider Buying and Selling

In related news, EVP Mark Stephen Katz purchased 3,215 shares of Ryan Specialty stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average cost of $31.07 per share, for a total transaction of $99,890.05. Following the transaction, the executive vice president owned 4,332 shares in the company, valued at approximately $134,595.24. The trade was a 287.82% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director John W. Rogers, Jr. purchased 7,500 shares of the firm’s stock in a transaction dated Wednesday, June 10th. The shares were purchased at an average cost of $35.16 per share, for a total transaction of $263,700.00. Following the purchase, the director directly owned 117,933 shares in the company, valued at approximately $4,146,524.28. This represents a 6.79% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last 90 days, insiders have purchased 130,715 shares of company stock valued at $4,263,590. Corporate insiders own 52.03% of the company’s stock.

Hedge Funds Weigh In On Ryan Specialty

Several hedge funds have recently bought and sold shares of the company. Pacer Advisors Inc. raised its holdings in Ryan Specialty by 21.3% during the fourth quarter. Pacer Advisors Inc. now owns 17,988 shares of the company’s stock worth $929,000 after purchasing an additional 3,155 shares during the last quarter. Invesco Ltd. grew its holdings in Ryan Specialty by 34.7% in the fourth quarter. Invesco Ltd. now owns 278,583 shares of the company’s stock valued at $14,383,000 after purchasing an additional 71,699 shares during the last quarter. Corient Private Wealth LLC increased its position in shares of Ryan Specialty by 5.0% in the fourth quarter. Corient Private Wealth LLC now owns 17,807 shares of the company’s stock valued at $919,000 after buying an additional 840 shares in the last quarter. Alberta Investment Management Corp acquired a new position in shares of Ryan Specialty during the 4th quarter worth $1,373,000. Finally, Vident Advisory LLC raised its stake in shares of Ryan Specialty by 11.0% during the 4th quarter. Vident Advisory LLC now owns 5,338 shares of the company’s stock worth $276,000 after buying an additional 529 shares during the last quarter. 84.82% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

RYAN has been the topic of a number of recent analyst reports. Zacks Research upgraded shares of Ryan Specialty from a “strong sell” rating to a “hold” rating in a research note on Tuesday, June 30th. Keefe, Bruyette & Woods lifted their price objective on Ryan Specialty from $44.00 to $48.00 and gave the company an “outperform” rating in a report on Wednesday, July 8th. Wells Fargo & Company boosted their target price on Ryan Specialty from $31.00 to $39.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 9th. Weiss Ratings reissued a “sell (d+)” rating on shares of Ryan Specialty in a report on Monday, May 4th. Finally, Mizuho lifted their price target on Ryan Specialty from $35.00 to $39.00 and gave the company a “neutral” rating in a research note on Thursday, July 9th. Eight analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Ryan Specialty has a consensus rating of “Hold” and a consensus target price of $50.00.

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.